Page last updated: 2024-09-04

gadolinium oxide and Carcinoma, Non-Small Cell Lung

gadolinium oxide has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jin, T; Wang, L; Xiao, X; Zhao, E; Zhou, X1
Chen, W; Jin, X; Li, F; Li, P; Li, Q; Li, Z; Liu, Y; Shen, Z; Wu, A; Zhang, P1

Other Studies

2 other study(ies) available for gadolinium oxide and Carcinoma, Non-Small Cell Lung

ArticleYear
Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer.
    Bioengineered, 2022, Volume: 13, Issue:1

    Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Drug Resistance, Neoplasm; Drug Synergism; Female; Gadolinium; Humans; Hyaluronic Acid; Lung Neoplasms; Male; Middle Aged; Nanoparticles; Neoplasm Staging; Particle Size; Protein Kinase Inhibitors; Radiotherapy, Conformal; Random Allocation; Survival Analysis; Treatment Outcome

2022
Ultra-small gadolinium oxide nanocrystal sensitization of non-small-cell lung cancer cells toward X-ray irradiation by promoting cytostatic autophagy.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Survival; DNA Damage; Endocytosis; Gadolinium; Humans; Hydroxyl Radical; Lung Neoplasms; Nanoparticles; Oxidative Stress; Particle Size; X-Rays

2019
chemdatabank.com